Gurbakhash Kaur, M.D.

Harold C. Simmons Comprehensive Cancer Center

Internal Medicine - Hematology/Oncology
Multiple Myeloma
Cellular therapy (CAR T-cell)

New Patient Appointment Accepting Virtual Visits or 214-645-4673

Biography

Gurbakhash Kaur, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in stem cell transplantation, immunotherapy, CAR T-cell therapy, and treating patients with multiple myeloma and other plasma cell disorders, including amyloidosis and Waldenström macroglobulinemia. She is also involved in clinical trials to develop novel therapeutics for multiple myeloma.

Dr. Kaur earned her medical degree at Drexel University College of Medicine. She completed a residency in internal medicine at Tufts Medical Center and received advanced training in hematology and oncology through a fellowship at Montefiore Medical Center.

Certified by the American Board of Internal Medicine in medical oncology and in hematology, she joined the UT Southwestern faculty in 2020.

Dr. Kaur’s clinical and research interests include improving outcomes for patients with hematologic malignancies, particularly multiple myeloma, by developing newer cellular and immunotherapy therapies, and she publishes and delivers presentations on her work regularly.

She is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the International Myeloma Society, among other professional organizations.

Education & Training

Medical School - Drexel University College of Medicine (2009-2013)
Residency - Tufts Medical Center (2013-2016), Internal Medicine
Fellowship - Montefiore Medical Center (2016-2019), Hematology Oncology
Graduate School - Boston University School of Medicine (2007-2009)

Professional Associations & Affiliations

American Society of Hematology
American Society of Clinical Oncology
International Myeloma Society
American Society for Transplantation and Cellular Therapy
European Hematology Association

Honors & Awards

Master’s Thesis with Honors 2009, Boston University School of Medicine
Techno-Genesis Summer Scholar 2005-2006, Stevens Institute of Technology

Books & Publications

Publications
- Treatment of Smoldering Myeloma: Problems With Study Design as well as Biological and Clinical Implications.
  Biran N, Vesole DH, Donato ML, Ip A, Kaur G, Goldberg S, Siegel DS, Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 Apr 38 12 1367-1368
- Multiple myeloma in Hispanics- incidence, characteristics and survival, results of a discovery & validation cohort using real world and CONNECT data
  Kaur et al Clinical Lymphoma, Myeloma and Leukemia 2020
- Immune checkpoint blockade and CAR-T cell therapy in hematologic malignancies.
  Wang H, Kaur G, Sankin AI, Chen F, Guan F, Zang X, Journal of hematology & oncology 2019 06 12 1 59
- B7x- From Bench to Bedside
  Kaur G, Janakiram M ESMO Open 2019
- Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience.
  Mato AR, Nabhan C, Barr PM, Ujjani CS, Hill BT, Lamanna N, Skarbnik AP, Howlett C, Pu JJ, Sehgal AR, Strelec LE, Vandegrift A, Fitzpatrick DM, Zent CS, Feldman T, Goy A, Claxton DF, Bachow SH, Kaur G, Svoboda J, Nasta SD, Porter D, Landsburg DJ, Schuster SJ, Cheson BD, Kiselev P, Evens AM, Blood 2016 11 128 18 2199-2205
- Translational research in pancreatic adenocarcinoma.
  Kaur G, Saif MW, JOP : Journal of the pancreas 2014 Mar 15 2 121-3

Research

Hematologic Malignancies
Immunotherapy
Health Care Disparities

Clinical Focus

Multiple Myeloma
Cellular therapy (CAR T-cell)
Bone Marrow Transplant
Amyloidosis
Monoclonal Gammopathies of Unknown Significance (MGUS)
Smoldering Myeloma
Waldenström Macroglobulinemia